What to expect in the Nurix Therapeutics, Inc. interview process

Based on publicly available information, Nurix Therapeutics, Inc. (ticker: NRIX) is a publicly traded biotechnology company founded in 2012 and headquartered in Brisbane, California, with additional offices in The Woodlands and San Francisco. The company operates as a biotech focused on a targeted protein degradation platform utilizing degraders and DACs for the treatment of cancer and autoimmune diseases.

Publicly available company data indicates that Nurix Therapeutics employs approximately 307 people, generates an annual revenue of $84 million, and went public via an IPO in 2020. The company's workforce is internationally distributed across six countries, including the United States, Portugal, France, India, and Bangladesh.

Regarding the hiring process and candidate experience, the company issues a specific security notice to job seekers. Candidates are explicitly warned that Nurix representatives will never conduct interviews via text, nor will they ever request personal financial information or ask candidates to purchase equipment as part of the hiring process.